How To Make a Glycopeptide: A Synthetic Biology Approach To Expand Antibiotic Chemical Diversity
- 5 August 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 2 (9) , 642-650
Abstract
Modification of natural product backbones is a proven strategy for the development of clinically useful antibiotics. Such modifications have traditionally been achieved through medicinal chemistry strategies or via in vitro enzymatic activities. In an orthogonal approach, engineering of biosynthetic pathways using synthetic biology techniques can generate chemical diversity. Here we report the use of a minimal teicoplanin class glycopeptide antibiotic (GPA) scaffold expressed in a production-optimized Streptomyces coelicolor strain to expand GPA chemical diversity. Thirteen scaffold-modifying enzymes from 7 GPA biosynthetic gene clusters in different combinations were introduced into S. coelicolor, enabling us to explore the criteria for in-cell GPA modification. These include identifying specific isozymes that tolerate the unnatural GPA scaffold and modifications that prevent or allow further elaboration by other enzymes. Overall, 15 molecules were detected, 9 of which have not been reported previously. Some of these compounds showed activity against GPA-resistant bacteria. This system allows us to observe the complex interplay between substrates and both non-native and native tailoring enzymes in a cell-based system and establishes rules for GPA synthetic biology and subsequent expansion of GPA chemical diversity.Keywords
Funding Information
- Canadian Institutes of Health Research (MFE 120913, MT-14981)
- Canada Research Chairs
This publication has 40 references indexed in Scilit:
- Characterization of the Post-Assembly Line Tailoring Processes in Teicoplanin BiosynthesisACS Chemical Biology, 2016
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales dataThe Lancet Infectious Diseases, 2014
- Tailoring Enzyme-Rich Environmental DNA Clones: A Source of Enzymes for Generating Libraries of Unnatural Natural ProductsJournal of the American Chemical Society, 2010
- Structure and Function of the Glycopeptide N-methyltransferase MtfA, a Tool for the Biosynthesis of Modified Glycopeptide AntibioticsChemistry & Biology, 2009
- Glycopeptide Biosynthesis: Dbv21/Orf2* from dbv/tcp Gene Clusters Are N-Ac-Glm Teicoplanin Pseudoaglycone Deacetylases and Orf15 from cep Gene Cluster Is a Glc-1-P ThymidyltransferaseJournal of the American Chemical Society, 2006
- Biosynthesis of Sulfated Glycopeptide Antibiotics by Using the Sulfotransferase StaLChemistry & Biology, 2006
- Tailoring of Glycopeptide Scaffolds by the Acyltransferases from the Teicoplanin and A-40,926 Biosynthetic OperonsChemistry & Biology, 2005
- Antibiotic optimization via in vitro glycorandomizationNature Biotechnology, 2003
- Incorporation of Glucose Analogs by GtfE and GtfD from the Vancomycin Biosynthetic Pathway to Generate Variant GlycopeptidesChemistry & Biology, 2002
- Glycopeptide Biosynthesis in Amycolatopsis mediterranei DSM5908Chemistry & Biology, 2002